USANA Financial Statements From 2010 to 2025

USNA Stock  USD 33.21  1.25  3.91%   
USANA Health financial statements provide useful quarterly and yearly information to potential USANA Health Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on USANA Health financial statements helps investors assess USANA Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting USANA Health's valuation are summarized below:
USANA Health Sciences does not now have any fundamental measures for analysis.
Check USANA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among USANA Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . USANA financial statements analysis is a perfect complement when working with USANA Health Valuation or Volatility modules.
  
Check out the analysis of USANA Health Correlation against competitors.

USANA Health Sciences Company Return On Equity Analysis

USANA Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current USANA Health Return On Equity

    
  0.11  
Most of USANA Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, USANA Health Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, USANA Health Sciences has a Return On Equity of 0.1083. This is 95.9% lower than that of the Personal Care Products sector and 102.05% lower than that of the Consumer Staples industry. The return on equity for all United States stocks is 134.94% lower than that of the firm.

USANA Health Sciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining USANA Health's current stock value. Our valuation model uses many indicators to compare USANA Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across USANA Health competition to find correlations between indicators driving USANA Health's intrinsic value. More Info.
USANA Health Sciences is rated fourth in return on equity category among its peers. It is rated fourth in return on asset category among its peers reporting about  0.75  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for USANA Health Sciences is roughly  1.34 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the USANA Health's earnings, one of the primary drivers of an investment's value.

About USANA Health Financial Statements

USANA Health stakeholders use historical fundamental indicators, such as USANA Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although USANA Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in USANA Health's assets and liabilities are reflected in the revenues and expenses on USANA Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in USANA Health Sciences. Please read more on our technical analysis and fundamental analysis pages.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. Usana Health operates under Packaged Foods classification in the United States and is traded on New York Stock Exchange. It employs 1978 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:
Check out the analysis of USANA Health Correlation against competitors.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.